Neuroinflammation has recently been recognized as one of the possible factors leading to the development of rosacea. As such, future therapies targeting this pathway could prove effective in rosacea treatment.
A recent study shows people with facial erythema were strongly associated with having poor health and negative personality traits. Participants reported negative impacts of rosacea emotionally, socially, and at work. Doctors should seek to address both the aesthetic as well as the psychological impacts of the disease.
The signs and symptoms of some dermatologic and rheumatologic diseases sometimes overlap, and a better understanding of their associations and subsequent clinical and laboratory evaluations can help in optimizing the treatment and management of this patient population.
A novel therapeutic approach with Pyratine-XR appears to be a helpful adjunct in the treatment of rosacea. This topical cytokine therapy offers patients another effective option for rosacea and is a much welcomed addition in the dermatologic armamentarium.